Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
116.11
+3.27 (2.89%)
Aug 12, 2026, 1:46 PM EDT - Market open
Rhythm Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $146 | Buy | Reiterates | $146 | +25.74% | Aug 10, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $136 → $150 | Buy | Reiterates | $136 → $150 | +29.19% | Aug 5, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $141 → $155 | Buy | Reiterates | $141 → $155 | +33.49% | Aug 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $143 | Buy | Reiterates | $143 | +23.16% | Aug 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $151 → $154 | Buy | Maintains | $151 → $154 | +32.63% | Aug 5, 2026 |
| Citi | Citi | Buy Maintains $142 → $143 | Buy | Maintains | $142 → $143 | +23.16% | Aug 5, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $155 → $160 | Buy | Maintains | $155 → $160 | +37.80% | Aug 5, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $149 | Buy | Reiterates | $149 | +28.33% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.